Sort by 'shares'
How Will New Imaging Techniques and Genomic Tests Help In Diagnosis and Management of Prostate Cancer.
Recent advances in prostate cancer has led to the discovery of many new imaging and genomic tests. Information on the new tests and techniques can help patients in making informed decisions regarding their prostate cancer diagnosis, treatments and management options…
Will Modern Therapies Replace Auto and Allo Transplants in Myeloma Treatment?
In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. In addition to this, there are many more drugs currently undergoing clinical trials. With so many more options for immunotherapy drugs coming…
A Novel, More Precise, and Effective T-Cell Immunotherapy Approach for Myeloma
A lot of research is being done in immunotherapy for myeloma that is leading to new treatment options for patients. Dr. Ivan Borrello of John Hopkins is working on a completely, novel approach. This involves enhancing white blood cells to create a…
HIFU for Prostate Cancer Finally Gets the FDA Nod. What to expect.
After more than 10 years of clinical trials, the Food and Drug Administration on October 9 approved the first high-intensity focused ultrasound (HIFU) device for ablation of prostate tissue. HIFU has already been approved for use in prostate tissue outside…
Role of Allogeneic Stem Cell Transplant in Myeloma Treatment with Dr. Krishna Komanduri
The role of allogeneic stem-cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the use of donor stem cell transplantation is highly debated in the medical field due to the safety…